| Serial Number | 79356741 |
| Word Mark | MICOT |
| Filing Date | Friday, September 30, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 30, 2024 |
| Registration Number | 7369590 |
| Registration Date | Tuesday, April 30, 2024 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, February 13, 2024 |
| Description of Mark | The mark consists of the term "MICOT" in stylized font where the letter "M" appears in a completed shaded oval design. |
| Goods and Services | Capsules for medicines; medicines for human purposes for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; injectable solutions for medical purposes for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; active pharmaceutical ingredients in the nature of pharmaceutical preparations used for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; biochemical medicines, namely, prescription pills, tablets, capsules, caplets and pharmaceutical preparations for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; pharmaceutical preparations for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; drugs for medical purposes, namely, pharmaceutical drug preparations for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; pre-filled syringes for medical purposes; chemical preparations for pharmaceutical purposes for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; chemico-pharmaceutical preparations for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; vaccines; dietetic substances adapted for medical use; feed additives for veterinary preparations for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; Medicated animal washes; preparations for destroying noxious animals |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, December 3, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Shaanxi Micot Pharmaceutical Technology |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Party Name | Shaanxi Micot Technology Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Party Name | Shaanxi Micot Technology Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Party Name | Shaanxi Micot Technology Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Event Date | Event Description |
| Thursday, December 1, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Saturday, December 3, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, December 7, 2022 | APPLICATION FILING RECEIPT MAILED |
| Monday, July 17, 2023 | ASSIGNED TO EXAMINER |
| Friday, July 21, 2023 | NON-FINAL ACTION WRITTEN |
| Saturday, July 22, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, August 18, 2023 | REFUSAL PROCESSED BY MPU |
| Friday, August 18, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, September 13, 2023 | REFUSAL PROCESSED BY IB |
| Saturday, December 16, 2023 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Monday, December 18, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, December 18, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, December 18, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, December 18, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, December 18, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, December 18, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 18, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 18, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 9, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, January 9, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, January 9, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, January 9, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, January 9, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 24, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, January 24, 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, January 24, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, February 13, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 13, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, February 14, 2024 | NOTIFICATION PROCESSED BY IB |
| Tuesday, April 30, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, April 30, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 30, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, October 28, 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, October 28, 2024 | FINAL DISPOSITION PROCESSED |
| Sunday, November 17, 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, May 29, 2025 | CHANGE OF NAME/ADDRESS REC'D FROM IB |